Bladder cancer-induced CVD mortality: Role of CAPG protein

PLoS One. 2026 Feb 17;21(2):e0338101. doi: 10.1371/journal.pone.0338101. eCollection 2026.ABSTRACTOBJECTIVE: Explore the causes and mechanisms of bladder cancer-induced Cardiovascular diseases (CVD) death.METHOD: We acquired bladder cancer patient data from the SEER database to evaluate CVD death ri

J Junwen Shen

The impact of levodopa on post-stroke depression: the ESTREL-depression-study

Eur Stroke J. 2026 Feb 9;11(2):aakag001. doi: 10.1093/esj/aakag001.ABSTRACTINTRODUCTION: Post-stroke depression (PSD) frequently occurs after acute stroke and negatively affects rehabilitation. Dopamine has beneficial effects on motivation and emotional stability. In stroke patients, low dopamine le

M Mirjam I Sauter

Workforce Detachment in Persons with Chronic Kidney Disease

Clin J Am Soc Nephrol. 2026 Feb 17. doi: 10.2215/CJN.0000001003. Online ahead of print.ABSTRACTBACKGROUND: Impaired kidney function is associated with mortality, cardiovascular events, and hospitalization as well as diminished functional capacity and health-related quality of life. We hypothesized t

R Rasmus Rørth

Residual lipid risk in atherosclerotic cardiovascular disease

Eur Heart J. 2026 Feb 17:ehag087. doi: 10.1093/eurheartj/ehag087. Online ahead of print.ABSTRACTDespite significant advances in lipid-lowering therapeutics, residual lipid risk persists in patients with or at risk of atherosclerotic cardiovascular disease (ASCVD), even after optimizing low-density l

B Børge G Nordestgaard